Protagonist Therapeutics Inc
XBER:PGF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Protagonist Therapeutics Inc
XBER:PGF
|
US |
|
M
|
McCormick & Company Inc
XBER:MCX
|
US |
|
C
|
CMS Energy Corp
XBER:CSG
|
US |
|
P
|
Pultegroup Inc
DUS:PU7
|
US |
|
Eurofins Scientific SE
PAR:ERF
|
LU |
|
S
|
Sumitomo Corp
F:SUMA
|
JP |
|
E
|
EDP Renovaveis SA
ELI:EDPR
|
ES |
|
Amtech Systems Inc
NASDAQ:ASYS
|
US |
|
I
|
IAR Systems Group AB
SWB:NC91
|
SE |
|
M
|
Meritage Homes Corp
F:MEY
|
US |
|
C
|
Celcuity Inc
NASDAQ:CELC
|
US |
|
3i Group PLC
LSE:III
|
UK |
|
T
|
Tate & Lyle PLC
F:TLY
|
UK |
|
E
|
Exelixis Inc
F:EX9
|
US |
|
F
|
freenet AG
F:FNA
|
DE |
Bankruptcy Probability
Protagonist Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Protagonist Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Protagonist Therapeutics Inc
NASDAQ:PTGX
|
8.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
458.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
203.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
160.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
121.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
68.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Protagonist Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Protagonist Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
